— Know what they know.
Not Investment Advice
Also trades as: 2126.HK (HKSE) · $vol 0M

JWCTF OTC

JW (Cayman) Therapeutics Co. Ltd
1W: +0.0% 1M: +0.0% 3M: -14.8% YTD: -43.8% 1Y: -58.9% 3Y: -56.6%
$0.20
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 49 · $84.2M mcap · 319M float · 0.0007% daily turnover · Short 100% of daily vol

📊 Key Metrics

TTM
$463M
Revenue
+36.2% YoY
$-951M
Net Income
+33.2% YoY
$-353M
Free Cash Flow
+56.9% YoY
51.8%
Gross Margin
-83.5%
Op. Margin
-45.3%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-98.4%
ROA-67.6%
ROIC-35.5%

Valuation

P/E-2.9
P/B2.1
EV/EBITDA0.0

Leverage

Debt/Equity0.56
Current Ratio1.43
Interest Cov.-68.3x

Quality Scores

Piotroski F4/9
Altman Z—
Beneish M-6.18

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms